Foundation
Critical Path Institute (TRxA) — research grants & fellowships
Critical Path Institute (TRxA)
- Deadline
- Varies by program — see funder site
About this grant
Critical Path Institute (TRxA) funds biomedical research (drug discovery). Programs, eligibility, and deadlines vary — see the funder's site for current opportunities.
Research areas
drug discovery
Related funding
Cures Within Reach — research grants & fellowships
Cures Within Reach
Alzheimer's Drug Discovery Foundation — research grants & fellowships
Alzheimer's Drug Discovery Foundation
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development
National Institutes of Health
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
National Institutes of Health
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Verified best-effort. Amounts, deadlines, and eligibility change, so always confirm on the funder's own page before applying.